홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
NVCR
#2239
NovoCure Limited Ordinary Shares
12.170
0
USD
+7.70%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+7.70%
월간 변동
-0.33%
6달 변화
-11.49%
년간 변동율
-11.49%
이전 종가
11.300
0
Open
12.170
0
Bid
Ask
Low
12.170
0
High
12.170
0
양
113
마켓
주식
헬스케어
NVCR
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
109.92 M
111.49 M
111.8 M
111.98 M
113.79 M
—
Valuation ratios
Enterprise value
3.77 B
2.52 B
2.5 B
1.86 B
1.57 B
8.45 B
Price to earnings ratio
-19.1
-11.8
-11.41
-8.02
-10.6
-41.83
Price to sales ratio
5.31
3.11
3.09
2.22
2.2
10.62
Price to cash flow ratio
-121.87
-64.68
-44.24
-41.1
-29.4
-179.41
Price to book ratio
8.92
1.34
1.36
1.01
4.23
7.94
EBITDA 비율에 대한 기업 가치
-20.02
-13.19
-12.75
-9.38
-11.55
-46.87
Profitability ratios
Return on assets %
-0.05
-0.03
-0.03
-0.03
-0.03
-0.12
Return on equity %
-0.18
-0.09
-0.11
-0.11
-0.07
-0.39
Return on invested capital %
-40.11
-22.21
-22.45
-21.99
-19.09
-85.73
Gross margin %
79.25
75.15
73.88
73.25
75.82
298.1
Operating margin %
-39.25
-24.43
-24.89
-21.54
-23.17
-94.03
EBITDA margin %
-43.39
-28.72
-28.95
-25.37
-25.32
-108.37
Net margin %
-40.88
-22.14
-25.28
-22.29
-14.05
-83.76
Liquidity ratios
Quick ratio
1.42
1.41
1.39
1.5
2.71
7.01
Current ratio
1.46
1.47
1.45
1.55
2.9
7.35
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.13
0.12
0.13
0.13
0.16
0.54
Solvency ratios
Debt to assets ratio
0.53
0.53
0.53
0.55
0.24
1.85
Debt to equity ratio
1.82
1.81
1.88
2.21
0.57
6.48
Long term debt to total assets ratio
0.08
0.53
0.53
0.55
0.24
1.85
Long term debt to total equity ratio
0.27
1.81
1.88
2.21
0.57
6.48
Per share metrics
Operating cash flow per share
-0.03
-0.32
-0.14
0.18
-0.16
-0.44
EBIT per share
-0.59
-0.34
-0.35
-0.32
-0.36
-1.38
EBITDA per share
-0.65
-0.4
-0.41
-0.38
-0.4
-1.59
Total debt per share
6.08
5.95
5.89
6.75
1.75
20.34
Cash per share
8.9
8.43
8.17
9.24
4.02
29.85
Net current asset value per share
10.26
9.88
9.71
10.72
5.8
36.11
Tangible book value per share
3.34
3.28
3.13
3.05
3.05
12.52
Working capital per share
3.25
3.14
2.99
3.79
3.8
13.71
Book value per share
3.34
3.28
3.13
3.05
3.05
12.52
뉴스
Humacyte, Inc. (HUMA) Reports Q4 Loss, Misses Revenue Estimates
노보큐어, Leerink 컨퍼런스에서 암 치료 전략 발표
Novocure at Leerink Conference: Strategic Growth in Cancer Treatment
Novocure's Optune Lua Gets Japan Reimbursement for NSCLC Treatment
NovoCure (NVCR) Reliance on International Sales: What Investors Need to Know
노보큐어, Optune Lua 기기 일본 보험 급여 승인
Novocure gains Japan reimbursement for Optune Lua device
NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates
NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript
Novocure Ltd earnings beat by $0.19, revenue topped estimates
Netflix and Palantir among market cap stock movers on Wednesday
노보큐어 실적 발표 예정: 췌장암 치료제 출시에 주목